Injection containing Vitamin D3 (600,000 IU) is a high-potency formulation designed for the treatment and prevention of severe vitamin D deficiency and related disorders such as rickets, osteomalacia, and hypocalcemia. Vitamin D3 (cholecalciferol) plays a critical role in calcium and phosphate metabolism, promoting bone mineralization and maintaining serum calcium levels within the physiological range. This injectable preparation is particularly indicated in patients who have malabsorption syndromes, severe deficiency unresponsive to oral supplementation, or conditions requiring rapid correction of vitamin D status. The administration of this high-dose vitamin D3 injection should be performed under medical supervision, with careful monitoring of serum calcium, phosphate, and vitamin D levels to avoid potential toxicity, including hypercalcemia and hypercalciuria. Contraindications include hypercalcemia, hypervitaminosis D, and hypersensitivity to any component of the formulation. Caution is advised in patients with renal impairment, sarcoidosis, or other granulomatous diseases due to altered vitamin D metabolism. This injection provides a convenient and effective means of delivering a substantial dose of vitamin D3, ensuring prompt therapeutic action in clinical scenarios necessitating urgent correction of deficiency. Proper dosing intervals and patient monitoring are essential to optimize therapeutic outcomes and minimize adverse effects.